Questa acquisizione non segnala alcun contenuto riproducibile per il video 7676282137372282143; i metadati pubblici qui sotto restano comunque indicizzati.

A "cure" for melanoma? Moderna's stock nearly tripling in one day might mean some think s… — @distilledscience

Pubblicato 21 ago 2026 (2 mesi fa)0 s2689 visualizzazioni

Statistiche del video

Conteggi pubblici dall’ultimo aggiornamento.

Visualizzazioni: 2689
Like: 66
Commenti: 1
Condivisioni: 7
Salvataggi: 6
Interazione: 2,75%
Durata: 0 s
Pubblicato: 21 ago 2026

Approfondimenti sul video

Il video TikTok «A "cure" for melanoma? Moderna's stock nearly tripling in one day might mean some think so. Soo let's separate the science from the stock chart. 🧪 The therapy is real and the mechanism is quite cool: sequence a patient's tumor, find up to 34 mutations only their cancer has, print a custom mRNA that teaches T cells to recognize them. Sort of like giving a "most wanted" poster for the immune system to recognize the invaders, one patient at a time. Here's what we actually know: - Phase 2b, 157 patients, five years of follow-up: 49% lower hazard of recurrence or death when added to Keytruda. 68.8% recurrence-free at five years vs 49.1%. This is the old data. - Phase 3, 1,137 patients: met both its recurrence and distant-metastasis endpoints, making it the first individualized mRNA cancer therapy ever to do that. A great milestone. What we’re still missing: ❓ This was a press release, not a study, and they DIDN’T DISCLOSE the actual numbers. No hazard ratio, no confidence interval, no stage breakdown. The press release that moved the stock 177% contained exactly zero effect estimates. ❌ Proof it helps people live longer: hopeful, but we’re not there yet. Survival data is immature in both trials. Recurrence-free survival measures time until the cancer comes back or the patient dies. It's not the same thing as cured. But still hopeful! Save this one. When the full data drops at the next medical meeting, I'll be back with the numbers. Sources in slide Primary papers: Khattak et al. 2026, J Clin Oncol (doi:10.1200/JCO-26-00835); Weber et al. 2024, The Lancet (doi:10.1016/S0140-6736(23)02268-7). #Science #cancer #sciencenews #health» di @distilledscience ha totalizzato 2689 visualizzazioni, 66 like, 1 commenti, 7 condivisioni nelle metriche pubbliche rilevate da questo indice. Il tasso di interazione è pari a 2,75% (like, commenti e condivisioni rispetto alle visualizzazioni). È stato pubblicato 2 mesi fa e dura 0 secondi. È stato salvato 6 volte.

Dati aggiornati al 26 ott 2026 (UTC), dall’ultimo aggiornamento pubblico acquisito da questo indice.

Avisha |🧬Scientist Mythbuster

@distilledscience

🧬Your Skeptical Scientist: Distilling Truth from Trends🤦‍♂️ #Optimalist 💪 - NYC Business: 📧 [email protected]

Vedi profilo

Follower: 567.686
Seguiti: 479
Like: 12.483.196
Video: 878

Hashtag in questo video

I link restano all’interno di questo indice.

#cancer #health #science

Domande frequenti